Pharma Giant Cipla Slapped with ₹774 Crore Income Tax Demand Amid New Obesity Drug Launch

Mumbai-based Cipla faces massive income tax demand of ₹774 crore over rule violations, including short deductions and disallowance of expenses, amid the launch of its new obesity drug.

CiplaIncome Tax DemandRule ViolationsObesity DrugPharmaceutical IndustryReal Estate MumbaiJul 16, 2024

Pharma Giant Cipla Slapped with ₹774 Crore Income Tax Demand Amid New Obesity Drug Launch
Real Estate Mumbai:Cipla, a leading pharmaceutical company based in Mumbai, has been handed a massive income tax demand of ₹774 crore. The demand notice cites additional taxes for rule violations, including short deductions, weighted deductions, and disallowance of expenses. This development comes at a time when the company is preparing to launch a new obesity drug.

The income tax demand of ₹773.44 crore covers assessment years from 2015-16 to 2022-23, excluding any tax refunds. Cipla has confirmed the demand in its regulatory filings and plans to appeal against the tax order. The company has stated that the tax demands are not applicable under the law.

The tax authorities have cited rule violations, including short deductions, wherein the company deducted less tax than the rate mentioned in the provisions. Additionally, weighted deductions allowed for companies to invest in the development of knowledge and research capabilities were also disallowed, as well as expenses incurred for business operations.

Cipla is a well-established pharmaceutical company that has been operating in India for over 80 years. The company has a strong presence in the domestic market and exports its products to over 80 countries worldwide. Despite the income tax demand, Cipla remains committed to its mission of providing affordable and innovative healthcare solutions to patients globally.

Information
Cipla is an Indian multinational pharmaceutical company that was founded in 1935. The company is headquartered in Mumbai and has a strong presence in the domestic market. Cipla is known for its innovative and affordable healthcare solutions and has a global footprint, with exports to over 80 countries.

Cipla is a leading pharmaceutical company that has been operating in India for over 80 years. The company is committed to providing innovative and affordable healthcare solutions to patients globally.

Frequently Asked Questions

What is the amount of income tax demand slapped on Cipla?

The income tax demand on Cipla is ₹774 crore.

What are the rule violations cited by the tax authorities?

The tax authorities have cited rule violations, including short deductions, weighted deductions, and disallowance of expenses.

What is Cipla's response to the income tax demand?

Cipla has stated that the tax demands are not applicable under the law and plans to appeal against the tax order.

What is the significance of the income tax demand on Cipla?

The income tax demand on Cipla is significant as it comes at a time when the company is preparing to launch a new obesity drug, and may impact its financial performance.

What is Cipla's commitment to its customers?

Cipla remains committed to its mission of providing affordable and innovative healthcare solutions to patients globally, despite the income tax demand.

Related News Articles

Boosting Affordable Housing: A Key Expectation from the Upcoming Union Budget
real estate news

Boosting Affordable Housing: A Key Expectation from the Upcoming Union Budget

The real estate sector has high hopes from the Modi 3.0 regime as the Union Budget for 2024-25 approaches, with a focus on affordable housing being a top priority.

July 14, 2024
Read Article
Premium Housing Takes Center Stage: Affordable Launches Drop 21% in April-June
real estate news

Premium Housing Takes Center Stage: Affordable Launches Drop 21% in April-June

Builders focus on premium units, leading to a 21% decline in affordable housing launches across 7 major cities

July 12, 2024
Read Article
Indian Metros Witness Surge in Property Prices in Q2 2024
Real Estate Pune

Indian Metros Witness Surge in Property Prices in Q2 2024

Geetanjali Homestate's report reveals growth trends in property prices across major cities in India, with Noida/Greater Noida and Gurgaon leading the way.

July 16, 2024
Read Article
Nimbus Projects' Stock Soars to New Heights, Outpacing the Industry
real estate news

Nimbus Projects' Stock Soars to New Heights, Outpacing the Industry

On October 27, 2024, Nimbus Projects, a microcap company in the construction and real estate sector, saw its stock price soar to an all-time high of Rs. 146.5, outperforming the sector by 4.15%.

October 27, 2024
Read Article
Real Estate Developers in Pune Voice Concerns Over 24-Hour Ban on Heavy Vehicles
Real Estate Pune

Real Estate Developers in Pune Voice Concerns Over 24-Hour Ban on Heavy Vehicles

The Builders Association of Pune has expressed their concerns over the 24-hour ban on heavy vehicles. According to real estate developer Sandesh Agarwal, the ban is causing significant disruptions in construction and material supply chains.

February 10, 2025
Read Article
Bengaluru Homebuyers Withdraw Cases from Karnataka Real Estate Regulatory Authority
Real Estate

Bengaluru Homebuyers Withdraw Cases from Karnataka Real Estate Regulatory Authority

Homebuyers of the Ozone Urbana project in Bengaluru have withdrawn all seven cases filed with the Karnataka Real Estate Regulatory Authority (KRERA), citing the body's inability to provide effective solutions.

March 25, 2025
Read Article